Solesence, Inc.

SLSN Consumer Defensive Household & Personal Products

Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.02 0.00 0.00%
Market cap
$70.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
1.02
Beneish M
−1.13
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
3 3 3 3

+8 more TTM periods

ROE
(15.61%) 5.88% 12.33% 10.09%
ROA
(4.60%) 1.80% 3.71% 3.20%
ROIC
(3.65%) 1.70% 3.50% 3.95%
Return on Tangible Assets
(17.42%) 3.32% 6.98% 5.66%
Average Days of Receivables
61.60 38.55 40.20 57.02
Free Cash Flow per Share
(0.01) (0.04) (0.15) (0.18)
Free Cash Flow
(0.85) (2.63) (10.71) (12.48)
Capital Expenditures
(1.86) (2.80) (2.14) (4.29)
Other line items
Cash ROIC
(2.98%) (8.47%) (34.95%) (44.34%)
Accounts Receivable Turnover
5.43 7.81 10.60 6.74
Accounts Payable Turnover
6.92 6.41 6.97 8.11
Inventory Turnover
2.50 2.25 2.61 2.72
Average Days of Payables
44.18 38.43 32.52 38.14
Days of Inventory on Hand
115.22 144.42 118.73 149.12
Tax Rate
0.00 0.00 (0.04) 0.00
Research and Development Expense of Revenue
7.42% 6.81% 6.59% 6.67%
Selling, General and Administrative Expense of Revenue
21.24% 18.37% 16.76% 16.23%
Share Based Compensation of Revenue
0.88% 0.88% 0.93% 0.99%
Interest Coverage
(1.28) 0.80 1.69 2.43
Operating CF/Net income
(0.42) 0.18 (4.79) (5.02)
Depreciation/Fixed assets
0.07 0.07 0.06 0.06
Capex/Depreciation
(1.72) (2.85) (2.39) (4.74)
Revenue per Share
0.78 0.86 0.88 0.88
Operating CF per Share
0.01 0.00 (0.12) (0.12)
Capex per Share
(0.03) (0.04) (0.03) (0.06)
Capex to Sales
0.03 0.05 0.03 0.07

Fold the line items

Columns are period end dates